Analysis of AH samples from the cohort of POAG patients (Supplementary Data 1) showed that AGT concentration did not change in glaucoma, whereas PEDF content increased dramatically with POAG progression, reaching approximately 10-fold excess at stage 3 of the disease (Fig. 3b). This evidence concerns the gene AGT and glaucoma.